anonymous
Guest
anonymous
Guest
I think it’s time We all show a little more decorum in this discussion. I’ve been following statins since the days of compactin. Clearly these are highly effective drugs, albeit with side effects that can be limiting. Having different options with different MOAs is in advance in medical care as the provider and the patient work to reaching goal. It’s been said over and over that lower is better, and as a whole, lower numbers have been associated with better outcomes. BA has the data for the label change to include outcomes and combined with Zetia offers a solid 40% plus reduction in LDL Two agents combined with outcomes data and QD pill dosing that has great coverage is a real great option for providers and patients. I’m proud to be able to carry my expertise into offices. Helping providers and patients reach goal and save lives is a noble professional place to be.
Oh please.
What board did you cut and paste this drivel from ?
You are saving lives ?
What a noble mission.
This must be the Scientific Hired, Highly Tenured and now Lipid Experts elevator pitch.